Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Secondary prevention of coronary heart disease in the elderly.

× No keyword cloud information.

23 in total

1. Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors: J A Staessen; J G Wang; L Thijs
Journal: Lancet Date: 2001-10-20 Impact factor: 79.321

2. The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study.

Authors: D Sparrow; T R Dawber
Journal: J Chronic Dis Date: 1978

3. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors: James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal: Lancet Date: 2002-11-23 Impact factor: 79.321

4. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register.

Authors: Kevin Carroll; Azeem Majeed; Caroline Firth; Jeremy Gray
Journal: J Public Health Med Date: 2003-03

5. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events.

Authors: L A Harker; J P Boissel; A J Pilgrim; M Gent
Journal: Drug Saf Date: 1999-10 Impact factor: 5.606

6. Results of the pilot study for the Hypertension in the Very Elderly Trial.

Authors: Christopher J Bulpitt; Nigel S Beckett; Jonathan Cooke; Dan L Dumitrascu; Blas Gil-Extremera; Choudomir Nachev; Maria Nunes; Ruth Peters; Jan A Staessen; Lut Thijs
Journal: J Hypertens Date: 2003-12 Impact factor: 4.844

7. Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction.

Authors: Zhengling Li; James D Otvos; Stefania Lamon-Fava; Wanda V Carrasco; Alice H Lichtenstein; Judith R McNamara; Jose M Ordovas; Ernst J Schaefer
Journal: J Nutr Date: 2003-11 Impact factor: 4.798

8. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.

Authors: Arja T Erkkilä; Seppo Lehto; Kalevi Pyörälä; Matti I J Uusitupa
Journal: Am J Clin Nutr Date: 2003-07 Impact factor: 7.045

9. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors: Fiona Turnbull
Journal: Lancet Date: 2003-11-08 Impact factor: 79.321

10. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors:
Journal: Lancet Date: 2002-07-06 Impact factor: 79.321

2 in total

Review 1. Drug treatment of chronic heart failure in the elderly.

Authors: Gregor Leibundgut; Matthias Pfisterer; Hans-Peter Brunner-La Rocca
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

2. The additional value of routine electrocardiograms in cardiovascular risk management of older people.

Authors: Wouter De Ruijter; Willem J J Assendelft; Peter W Macfarlane; Rudi G J Westendorp; Jacobijn Gussekloo
Journal: Scand J Prim Health Care Date: 2008 Impact factor: 2.581

2 in total